Related by context. Frequent words. (Click for all words.) 67 Pivotal Phase 64 Initiates Phase 63 placebo controlled Phase 63 Presents Positive 62 Pivotal Phase III 61 Completes Enrollment 60 Phase Ib clinical 60 Patient Enrollment 60 Arch Neurol 59 Diabetic Macular Edema 59 Chronic Hepatitis C 59 Randomized controlled 59 multicenter randomized double 59 Clinical Trial Results 59 J Clin Oncol 58 phase IIb 58 relapsed refractory multiple myeloma 58 J Natl Cancer Inst 58 Multicenter 58 Phase III Clinical Trial 58 Phase III randomized 58 Metastatic Melanoma 57 phase IIb clinical 57 J Am Acad 57 J Am Coll 57 double blinded placebo 57 Pivotal Trial 57 blind randomized placebo 57 Arch Intern Med 57 J Clin Endocrinol Metab 57 Bioavailability 57 PRECiSE 57 RADIANT 57 EXECUTIVE SUMMARY 57 Hypoactive Sexual Desire Disorder 57 Phase 2a clinical 57 By KBJR News 57 phase IIa 56 Acute Myocardial Infarction 56 Risk Factors Item 56 e# [005] 56 Phase Ia 56 dose escalation trial 56 Free Full Text 56 Phase III Trial 56 Phase 1a 56 randomized Phase III 56 label multicenter 56 Phase 1b clinical 56 label dose escalation 55 Dermatol 55 Obstet Gynecol 55 TRITON TIMI 55 SPIRIT IV 55 Cardiol 55 plus dexamethasone 55 Cancer Res 55 blind randomized controlled 55 elotuzumab 55 Phase 1b trial 55 placebo controlled clinical 55 Meta Analysis 55 relapsing multiple sclerosis 55 ATTAIN 55 By Arek Sarkissian 55 randomized Phase 55 prospective observational 54 Ann Intern Med 54 J Biol Chem 54 CD# [004] 54 Pharmacokinetic 54 liposomal formulation 54 pharmacokinetics PK 54 randomized controlled clinical 54 multicenter randomized 54 placebo controlled randomized 54 Phase IIa clinical 54 Systematic Review 54 pgs #k 54 Noncritical violations found 54 Abstract Full Text 54 Amrubicin 53 registrational trial 53 ZYBRESTAT 53 SPIRIT III 53 nitazoxanide 53 CR# vcMMAE 53 adecatumumab 53 Preclinical Data 53 Phase 2a trial 53 Abstract Free Full Text 53 Nephrol 53 Allovectin 7 R 53 dose cohorts 53 CrossRef Medline 53 prospective multicenter 53 Immunogenicity 53 Thrombolysis 53 ILLUMINATE 53 Phase IIb trials 53 blinded placebo controlled